OpenURL Connection Search

Select item for more details and to access through your institution.

Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019.
Published in:
Open Forum Infectious Diseases, 2022, v. 9, n. 8, p. 1, doi. 10.1093/ofid/ofac406
By:
- Kim, Jin Yong;
- Săndulescu, Oana;
- Preotescu, Liliana-Lucia;
- Rivera-Martínez, Norma E;
- Dobryanska, Marta;
- Birlutiu, Victoria;
- Miftode, Egidia G;
- Gaibu, Natalia;
- Caliman-Sturdza, Olga;
- Florescu, Simin-Aysel;
- Shi, Hye Jin;
- Streinu-Cercel, Anca;
- Streinu-Cercel, Adrian;
- Lee, Sang Joon;
- Kim, Sung Hyun;
- Chang, Ilsung;
- Bae, Yun Ju;
- Suh, Jee Hye;
- Chung, Da Rae;
- Kim, Sun Jung
Publication type:
Article
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019.
Published in:
Open Forum Infectious Diseases, 2022, v. 9, n. 4, p. 1, doi. 10.1093/ofid/ofac053
By:
- Streinu-Cercel, Anca;
- Săndulescu, Oana;
- Preotescu, Liliana-Lucia;
- Kim, Jin Yong;
- Kim, Yeon-Sook;
- Cheon, Shinhye;
- Jang, Young Rock;
- Lee, Sang Joon;
- Kim, Sung Hyun;
- Chang, Ilsung;
- Suh, Jee Hye;
- Lee, Seul Gi;
- Kim, Mi Rim;
- Chung, Da Rae;
- Kim, Han Na;
- Streinu-Cercel, Adrian;
- Eom, Joong Sik
Publication type:
Article
Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics.
Published in:
Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 144, doi. 10.1002/cpdd.847
By:
- Cheeti, Sravanthi;
- Deng, Yuzhong;
- Chang, Ilsung;
- Georgescu, Isabela;
- Templeton, Ian;
- Choong, Nicholas;
- Cheung, Kit Wun Kathy;
- Girish, Sandhya;
- Musib, Luna
Publication type:
Article
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors.
Published in:
Investigational New Drugs, 2021, v. 39, n. 1, p. 163, doi. 10.1007/s10637-020-00975-6
By:
- Shapiro, Geoffrey I.;
- LoRusso, Patricia;
- Cho, Daniel C.;
- Musib, Luna;
- Yan, Yibing;
- Wongchenko, Matthew;
- Chang, Ilsung;
- Patel, Premal;
- Chan, Iris T.;
- Sanabria-Bohorquez, Sandra;
- Meng, Raymond D.;
- Bendell, Johanna C.
Publication type:
Article
Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects.
Published in:
British Journal of Clinical Pharmacology, 2012, v. 74, n. 5, p. 788, doi. 10.1111/j.1365-2125.2012.04281.x
By:
- Graham, Richard A.;
- Hop, Cornelis E. C. A.;
- Borin, Marie T.;
- Lum, Bert L.;
- Colburn, Dawn;
- Chang, Ilsung;
- Shin, Young G.;
- Malhi, Vikram;
- Low, Jennifer A.;
- Dresser, Mark J.
Publication type:
Article
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF<sup>V600</sup> mutation-positive melanoma.
Published in:
2018
By:
- Dréno, Brigitte;
- Ascierto, Paolo A;
- Atkinson, Victoria;
- Liszkay, Gabriella;
- Maio, Michele;
- Mandalà, Mario;
- Demidov, Lev;
- Stroyakovskiy, Daniil;
- Thomas, Luc;
- de la Cruz-Merino, Luis;
- Dutriaux, Caroline;
- Garbe, Claus;
- Bartley, Karen;
- Karagiannis, Thomas;
- Chang, Ilsung;
- Rooney, Isabelle;
- Koralek, Daniel O;
- Larkin, James;
- McArthur, Grant A;
- Ribas, Antoni
Publication type:
journal article
The effects of a high-fat meal on single-dose vemurafenib pharmacokinetics.
Published in:
Journal of Clinical Pharmacology, 2014, v. 54, n. 4, p. 368, doi. 10.1002/jcph.255
By:
- Ribas, Antoni;
- Zhang, Weijiang;
- Chang, Ilsung;
- Shirai, Keisuke;
- Ernstoff, Marc S.;
- Daud, Adil;
- Cowey, C. Lance;
- Daniels, Gregory;
- Seja, Elizabeth;
- O'Laco, Elizabeth;
- Glaspy, John A.;
- Chmielowski, Bartosz;
- Hill, Todd;
- Joe, Andrew K.;
- Grippo, Joseph F.
Publication type:
Article
coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF<sup>V600</sup> mutation-positive patients with unresectable locally advanced or metastatic melanoma (NCT01689519).
Published in:
2015
By:
- Ascierto, Paolo A.;
- McArthur, Grant A.;
- Dréno, Brigitte;
- Larkin, James;
- Liszkay, Gabriella;
- Maio, Michele;
- Mandala, Mario;
- Demidov, Lev;
- Stroyakovskiy, Daniil;
- Thomas, Luc;
- de la Cruz-Merino, Luis;
- Atkinson, Victoria;
- Dutriaux, Caroline;
- Garbe, Claus;
- Ilsung Chang;
- Hack, Stephen P.;
- Ribas, Antoni
Publication type:
Abstract
Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer.
Published in:
Oncologist, 2018, v. 23, n. 6, p. 654, doi. 10.1634/theoncologist.2017-0690
By:
- von Pawel, Joachim;
- Spigel, David R.;
- Ervin, Thomas;
- Losonczy, György;
- Barlesi, Fabrice;
- Juhász, Erzsébet;
- Anderson, Maria;
- McCall, Bruce;
- Wakshull, Eric;
- Hegde, Priti;
- Ye, Weilan;
- Chen, Daniel;
- Chang, Ilsung;
- Rhee, Ina;
- Reck, Martin
Publication type:
Article
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer.
Published in:
Oncologist, 2017, v. 22, n. 4, p. 375, doi. 10.1634/theoncologist.2016-0133
By:
- García‐Carbonero, Rocío;
- van Cutsem, Eric;
- Rivera, Fernando;
- Jassem, Jacek;
- Gore, Ira;
- Tebbutt, Niall;
- Braiteh, Fadi;
- Argiles, Guillem;
- Wainberg, Zev A.;
- Funke, Roel;
- Anderson, Maria;
- McCall, Bruce;
- Stroh, Mark;
- Wakshull, Eric;
- Hegde, Priti;
- Ye, Weilan;
- Chen, Daniel;
- Chang, Ilsung;
- Rhee, Ina;
- Hurwitz, Herbert
Publication type:
Article

Found: 10